Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Sage Therapeutics, Biogen get ZURZUVAE FDA approval for postpartum depression treatment Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA)… byPallavi MadhirajuAugust 5, 2023